Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Y Katherine Xu is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/18/2025 | INCY | Buy Now | Incyte | $60.41 | — | Y Katherine Xu75% | — | Downgrade | Outperform → Market Perform | Get Alert |
01/24/2019 | INCY | Buy Now | Incyte | $60.41 | 65.54% | Y Katherine Xu75% | $85 → $100 | Upgrade | Market Perform → Outperform | Get Alert |
04/06/2018 | INCY | Buy Now | Incyte | $60.41 | — | Y Katherine Xu75% | — | Downgrade | Outperform → Market Perform | Get Alert |
09/18/2017 | ARWR | Buy Now | Arrowhead Pharma | $15.04 | — | Y Katherine Xu75% | — | Upgrade | Market Perform → Outperform | Get Alert |
01/25/2017 | ALBO | Buy Now | Albireo Pharma | — | — | Y Katherine Xu75% | — | Initiates | → Outperform | Get Alert |
11/30/2016 | ARWR | Buy Now | Arrowhead Pharma | $15.04 | — | Y Katherine Xu75% | — | Downgrade | Outperform → Market Perform | Get Alert |